Anavex Life Sciences Corp (AVXL)

[BesaoT35]

Jim Cramer on CNBC today around 9:30 ET discussed in some detail that Lilly has a new drug for Alzheimer’s that he thinks could receive FDA approval by the end of March 2024. He thinks that it is going to be a game changer for Alzheimer’s. I do read this AVXL board fairly regularly. I have not seen the Lilly drug discussed here or maybe I missed it.

Can anyone with knowledge about the field of Alzheimer’s treatment elaborate on this Lilly product. Could the AVXL drugs be used in combination with the Lilly drug? What is the name of the Lilly drug? What is the mechanism of action? Is it a small molecule oral drug that is simple to administer like the AVXL products?

The Lilly stock price is doing very well. They already have a blockbuster success with their GLP-1 agonist drugs for diabetes and for obesity. The AVXL stock price in stark contrast does not reflect much investor optimism. The phase 2b-3 for Alzheimer’s was declared to meet all end points in December of 2022 but that seems to be not believed to be true by Wall Street or by scientists in Neurology except for a few distinguished researchers. The peer reviewed article in a reputable journal could change things for us as would regulatory approval. Has Cramer ever mentioned AVXL?

Thanks.